You are here

Grifols Announces US Launch of Flebogamma 10% DIF IVIG

Building on the safety record of its 5% concentration, the new 10% liquid, room temperature IVIG preparation establishes Grifols as the only producer offering both 5% and 10% IVIG concentrations to healthcare providers and patients in the US.

Grifols Announces US Launch of Flebogamma® 10% DIF IVIG

News Category: